FIELD: medicine, phthisiology. SUBSTANCE: the method in question deals with carrying out etiopathogenetic therapy along with introduction of betaleukin. The innovation enables to increase efficiency due to decreased number of complications and relapses. EFFECT: higher efficiency of therapy. 2 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING ACUTE MILIARY PULMONARY TUBERCULOSIS | 1999 |
|
RU2188034C2 |
METHOD OF TREATING PULMONARY TUBERCULOSIS FEATURING PREDOMINANTLY EXUDATIVE TYPE OF INFLAMMATION | 1990 |
|
RU2008902C1 |
AGENT ENHANCING EFFECTIVENESS OF TREATMENT OF PATIENTS WITH TUBERCULOSIS | 1996 |
|
RU2136276C1 |
METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 2001 |
|
RU2229892C2 |
METHOD FOR TREATMENT OF DESTRUCTIVE AND PROGRESSING LUNG TUBERCULOSIS FORMS CAUSED BY DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS | 2000 |
|
RU2215538C2 |
METHOD FOR TREATING THE CASES OF RESPIRATORY ORGAN TUBERCULOSIS WITH MARKED EXUDATION RESPONSE IN CHILDREN | 2000 |
|
RU2189234C2 |
METHOD OF TREATMENT OF EXPERIMENTAL TUBERCULOSIS | 2001 |
|
RU2207127C1 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
METHOD FOR TREATING TUBERCULAR EPIDIDYMITIS | 1999 |
|
RU2204391C2 |
METHOD FOR TREATING THE CASES OF TUBERCULOSIS | 2002 |
|
RU2212240C1 |
Authors
Dates
2003-05-20—Published
2000-04-25—Filed